As the EGFR C797S mutation was the most common resistance mechanism to AZD9291 in T790M-positive NSCLC patients who failed prior EGFR TKIs [8, 13], we analyzed this mutation in PC9/AZDR cells. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.